Building capacity across the radiopharmaceutical value chain is proving to be a significant challenge given the need for specialized facilities, according to the firm.
The expanded BARDA agreement adds approximately $270 million in procurement through 2031 as the company advances an investigational antibody against another Ebola virus species.
The bioprocessing supplier has opened an X-ray irradiation facility, begun a second phase of campus construction, and introduced an automated bulk-product aliquoting platform.
Explore the essential role of precision in pharmaceutical quality control. Learn how lab balances support raw material verification and product formulation. Understand regulatory requirements such as USP Chapters <41> and <1251> and discover strategies to manage sample volumes while maintaining precision. Address data integrity and compliance challenges with Cubis® III balances.
As AI and manufacturing growth accelerate, Life Sciences leaders must rethink power, cooling, and resiliency. Join this webinar for practical infrastructure strategies.
